Clinical trial for Amyotrophic Lateral Sclerosis (ALS)
Official title Identification of Early Markers for ALS
ClinicalTrials.gov ID: NCT07213440
What this study is testing
- Who it's for
- People with ALS or those at risk for the disease.
- What's involved
- Participants will provide samples so researchers can look for specific molecular markers.
- Time commitment
- The duration and specific visit schedule are not listed in the provided text.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90. Healthy volunteers may be eligible.
You may be able to join if
- 18-90 years of age
- Provision of a written informed consent
- Affiliation with a social security scheme or beneficiary of such a scheme
- Diagnosed by a clinically certified laboratory with a disease- causing mutation in a known ALS gene by predictive genetic testing
- 18-90 years of age
You likely can't join if
- Inability to express consent to the study
- Persons subject to a judicial safeguard measure, under guardianship or curatorship.
- Linguistic incapacity or psychic refusal to read the information.
- Pregnant women
- Foreseen inability to attend scheduled visits
- Persons refusing to take one of the following samples: Acquisition of blood samples, Acquisition of tear fluid samples, Acquisition of urine sample
See the full eligibility criteria
- 18-90 years of age
- Provision of a written informed consent
- Affiliation with a social security scheme or beneficiary of such a scheme
- Diagnosed by a clinically certified laboratory with a disease- causing mutation in a known ALS gene by predictive genetic testing
- 18-90 years of age
- Provision of a written informed consent
- Affiliation with a social security scheme or beneficiary of such a scheme
- No known genetic mutation and no known ALS disease in close family
- No diagnosed motor-neuron disease THIRD GROUP: ALS (EALS) / ALS mimics (MIM)
- 18-90 years of age
- provision of a written informed consent
- affiliation with a social security scheme or beneficiary of such a scheme
- Patients with pure motor symptom or early ALS (EALS) or ALS mimics (MIM) EALS are patients with pure motor symptom / early motor symptoms of ALS, including those, where the diagnosis of ALS can already be made.
- Inability to express consent to the study
- Persons subject to a judicial safeguard measure, under guardianship or curatorship.
- Linguistic incapacity or psychic refusal to read the information.
- Pregnant women
- Foreseen inability to attend scheduled visits
- Persons refusing to take one of the following samples: Acquisition of blood samples, Acquisition of tear fluid samples, Acquisition of urine sample
The study team makes the final eligibility decision.
Where it is enrolling
- Tours, France, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Tours, France, France. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.